Browse all categories:

Improved colour blindness symptoms associated with recreational psychedelic use

It is well documented that psychedelic drugs can have a profound effect on colour perception. After previous research involving psychedelic drug ingestion, several participants had written to the authors describing how symptoms of their colour blindness had improved. The Global Drugs Survey runs the world’s largest annual online drug survey. In the Global Drugs Survey  …


The United Nations Commission on Narcotic Drugs 2020

Drug Science was invited to give expert commentary on: Thematic session 3:The availability of internationally controlled substances for medical and scientific purposes, including for the relief of pain and palliative care, remains low to non-existent in many parts of the world; (21 October 2020) After earlier speakers focused on the availability, or lack thereof, of  …


Project Twenty21 - an eventful first year!

In November 2019, Drug Science launched Project Twenty21 – Europe’s first and biggest national medical cannabis registry. The project was set up for simple reasons. Even after legislation around cannabis based medical products (CBMPs) was changed by the UK Government, too many people are still unable to access these treatments. The cost of these medications  …


New Zealand Cannabis Referendum 2020

By Dr. Meg Spriggs and Professor David Nutt  On October 17th 2020, New Zealanders will be given the opportunity to change the way recreational cannabis use is viewed and treated. At present, recreational cannabis use¹ is illegal under the Misuse of Drugs Act 1975 (either class B or C depending on its form). Despite this,  …


South Africa decriminalises personal possession of cannabis

Prof David Nutt spent 10 days providing evidence to the South African courts in 2017 - he reflects on South Africa's positive decision to reform its cannabis laws. A great day for South Africa drug policy from DrugScience on Vimeo.         Related Content The United Nations Commission on Narcotic Drugs 2020October 22  …

Harm Reduction in Public Policy - the UK and the US – A DrugScience evening reception at the House of Lords

On Wednesday 30 May 2018, DrugScience hosted an evening reception at the House of Lords, in partnership with Harm Reduction International. Sponsored by DrugScience trustee Lord Nick Rea, the evening featured presentations on the latest strategic approaches to reduce the negative consequences associated with risk behaviours and addiction, the challenging global funding environment for harm  …

Better late than never? After 82 years the WHO reviews cannabis!

The WHO is the world’s leading health organisation guiding governments around the world. So we expect their advice to be up to date and evidence-based, particularly on controversial topics. One of the most controversial topics of our time is the international community’s approach to drug policy, particularly that relating to the most popular so-called “illegal”  …

New Zealand revises sentencing framework for methamphetamine offences

Dr James Foulds, Consultant forensic psychiatrist, Christchurch New Zealand Methamphetamine smoking is the commonest form of stimulant use in New Zealand. Asian importation has increased recently, and the drug has got much cheaper. However, despite harsh sanctions, dealing remains attractive for many people- including those who sell the drug to fund their own use. Until  …


Looking back on the establishment of Drug Science

I first came across David Nutt in July 2007, when he spoke at a conference called ‘Criminal Justice and Social Justice’, which the Centre for Crime and Justice Studies held at King’s College London. David spoke on the subject of ‘Why adopt a harm approach in relation to drugs?’. Here was someone, I thought at  …


NICE on cannabidiol for childhood epilepsy

At the end of last week, NICE released their initial appraisal on cannabidiol in the form of Epidiolex for childhood epilepsy.  As predicted by Drug Science experts they found against it on the grounds of cost-benefit. We don’t have the company submission regarding cost/benefit analysis, and consequently cannot comment on those, but we can reflect  …


Press Release: Government decision on cannabis-related medicinal products draws criticism from independent scientific body, Drug Science.

Today (13th August 2019), the independent scientific body Drug Science has responded with disappointment to a decision by the National Institute for Health and Care Excellence (NICE), relating to cannabis-related medical products. In November 2018, the then Home Secretary Sajid Javid introduced regulations so that cannabis-derived medicinal products would be available on prescription. This change  …